Article info
PDFOriginal research
Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis
- Correspondence to Aili V Langford, Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW 2790, Australia; aili.langford{at}sydney.edu.au
Citation
Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis
Publication history
- Received January 15, 2020
- Revised March 5, 2020
- Accepted March 12, 2020
- First published March 27, 2020.
Online issue publication
January 19, 2021
Article Versions
- Previous version (19 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.